RAGE and arthritis

The G82S polymorphism amplifies the inflammatory response

M. A. Hofmann, S. Drury, B. I. Hudson, M. R. Gleason, W. Qu, Y. Lu, E. Lalla, S. Chitnis, J. Monteiro, M. H. Stickland, L. G. Bucciarelli, B. Moser, G. Moxley, S. Itescu, P. J. Grant, P. K. Gregersen, David Stern, A. M. Schmidt

Research output: Contribution to journalArticle

300 Citations (Scopus)

Abstract

The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)123-135
Number of pages13
JournalGenes and Immunity
Volume3
Issue number3
DOIs
StatePublished - May 1 2002

Fingerprint

Arthritis
Leukocyte L1 Antigen Complex
Alleles
Rheumatoid Arthritis
Matrix Metalloproteinase 13
Ligands
Matrix Metalloproteinase 3
Collagen Type II
Immune System Diseases
Matrix Metalloproteinase 9
Matrix Metalloproteinases
Glycine
Serine
Ligation
Advanced Glycosylation End Product-Specific Receptor
Case-Control Studies
Interleukin-6
Up-Regulation
Tumor Necrosis Factor-alpha
Joints

All Science Journal Classification (ASJC) codes

  • Immunology
  • Genetics
  • Genetics(clinical)

Cite this

Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., ... Schmidt, A. M. (2002). RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes and Immunity, 3(3), 123-135. https://doi.org/10.1038/sj.gene.6363861

RAGE and arthritis : The G82S polymorphism amplifies the inflammatory response. / Hofmann, M. A.; Drury, S.; Hudson, B. I.; Gleason, M. R.; Qu, W.; Lu, Y.; Lalla, E.; Chitnis, S.; Monteiro, J.; Stickland, M. H.; Bucciarelli, L. G.; Moser, B.; Moxley, G.; Itescu, S.; Grant, P. J.; Gregersen, P. K.; Stern, David; Schmidt, A. M.

In: Genes and Immunity, Vol. 3, No. 3, 01.05.2002, p. 123-135.

Research output: Contribution to journalArticle

Hofmann, MA, Drury, S, Hudson, BI, Gleason, MR, Qu, W, Lu, Y, Lalla, E, Chitnis, S, Monteiro, J, Stickland, MH, Bucciarelli, LG, Moser, B, Moxley, G, Itescu, S, Grant, PJ, Gregersen, PK, Stern, D & Schmidt, AM 2002, 'RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response', Genes and Immunity, vol. 3, no. 3, pp. 123-135. https://doi.org/10.1038/sj.gene.6363861
Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y et al. RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes and Immunity. 2002 May 1;3(3):123-135. https://doi.org/10.1038/sj.gene.6363861
Hofmann, M. A. ; Drury, S. ; Hudson, B. I. ; Gleason, M. R. ; Qu, W. ; Lu, Y. ; Lalla, E. ; Chitnis, S. ; Monteiro, J. ; Stickland, M. H. ; Bucciarelli, L. G. ; Moser, B. ; Moxley, G. ; Itescu, S. ; Grant, P. J. ; Gregersen, P. K. ; Stern, David ; Schmidt, A. M. / RAGE and arthritis : The G82S polymorphism amplifies the inflammatory response. In: Genes and Immunity. 2002 ; Vol. 3, No. 3. pp. 123-135.
@article{e5870e7f68c5485ba2c8a59cc8f60439,
title = "RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response",
abstract = "The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.",
author = "Hofmann, {M. A.} and S. Drury and Hudson, {B. I.} and Gleason, {M. R.} and W. Qu and Y. Lu and E. Lalla and S. Chitnis and J. Monteiro and Stickland, {M. H.} and Bucciarelli, {L. G.} and B. Moser and G. Moxley and S. Itescu and Grant, {P. J.} and Gregersen, {P. K.} and David Stern and Schmidt, {A. M.}",
year = "2002",
month = "5",
day = "1",
doi = "10.1038/sj.gene.6363861",
language = "English (US)",
volume = "3",
pages = "123--135",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - RAGE and arthritis

T2 - The G82S polymorphism amplifies the inflammatory response

AU - Hofmann, M. A.

AU - Drury, S.

AU - Hudson, B. I.

AU - Gleason, M. R.

AU - Qu, W.

AU - Lu, Y.

AU - Lalla, E.

AU - Chitnis, S.

AU - Monteiro, J.

AU - Stickland, M. H.

AU - Bucciarelli, L. G.

AU - Moser, B.

AU - Moxley, G.

AU - Itescu, S.

AU - Grant, P. J.

AU - Gregersen, P. K.

AU - Stern, David

AU - Schmidt, A. M.

PY - 2002/5/1

Y1 - 2002/5/1

N2 - The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.

AB - The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=0036562502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036562502&partnerID=8YFLogxK

U2 - 10.1038/sj.gene.6363861

DO - 10.1038/sj.gene.6363861

M3 - Article

VL - 3

SP - 123

EP - 135

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 3

ER -